Log In
Print this Print this

Aptivus, tipranavir

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionNon-peptidic protease inhibitor (PI)
Molecular Target HIV protease
Mechanism of ActionViral protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection in nonnucleoside reverse transcriptase inhibitor (NNRTI)-naïve patients who have failed 2 or more protease inbitor regimens; Treat HIV infection/AIDS; Treat HIV-1 infection in adults with evidence of viral replication and who are highly treatment experienced or who have multiple protease inhibitor resistance; Treat HIV-1 infection in combination with other antiretroviral agents in patients who are protease inhibitor experienced
Regulatory Designation U.S. - Accelerated Approval (Treat HIV infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today